DBV Technologies S.A. (DBVT)Healthcare | Biotechnology | Châtillon, France | NasdaqCM
13.54 USD
-0.87
(-6.037%) ⇩
(Aug. 28, 2026, 4 p.m.
EDT)
After hours: 13.72 +0.18 (1.329%) ⇧ (Aug. 28, 2026, 6:49 p.m. EDT) |
Hot Take ↕ | Aug. 22, 2026, 3:03 a.m. EDT
The investment case here is fundamentally broken despite the recent price recovery. While the stock has rallied nearly 1,000% year-over-year, this is a classic 'dead cat bounce' off a precipice; the business is hemorrhaging cash with negative free cash flow exceeding $100 million and operating margins in the low -70s. Revenue has contracted by more than half, and the company is burning through its meager cash reserves. The balance sheet offers no safety net, and the massive analyst price targets are disconnected from the reality of a shrinking, unprofitable operation. On the short end, the heavy put activity and elevated implied volatility suggest traders are hedging against further deterioration, keeping the immediate outlook neutral-to-bearish. There is no dividend to provide income, and the long-term outlook remains dire as the core business metrics continue to deteriorate. |
| Model | MAE |
|---|---|
| AutoETS ✓ | 0.096590 |
| AutoARIMA | 0.096592 |
| MSTL | 0.100531 |
| AutoTheta | 0.235782 |
Forecast horizon: 45 days | Selected: AutoETS
| Forecast Reliability | |
|---|---|
| Score | 26% |
| H-stat | 8.12 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.116 |
| Excess Kurtosis | -0.70 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 4.8 |
| Revenue per Share | 0.085 |
| Market Cap | 850,932,288 |
| Forward P/E | -25.24 |
| Beta | -0.24 |
| Website | https://www.dbv-technologies.com |
As of Aug. 22, 2026, 3:03 a.m. EDT: Speculators are aggressively positioning for downside protection with heavy open interest in out-of-the-money puts expiring soon, while call volume remains negligible. Implied volatility is significantly elevated for near-term puts compared to longer-dated strikes, indicating a fear premium rather than a bullish expectation. The lack of call activity suggests the market views any potential upside as limited or highly speculative.
| Attribute | Value |
|---|---|
| 52 Week Change | 0.5697168 |
| Address1 | BAtiment IRO |
| Address2 | 107 Av. de la REpublique |
| All Time High | 101.14 |
| All Time Low | 0.441 |
| Ask | 14.34 |
| Ask Size | 1 |
| Average Daily Volume10 Day | 163,460 |
| Average Daily Volume3 Month | 300,653 |
| Average Volume | 300,653 |
| Average Volume10Days | 163,460 |
| Beta | -0.236 |
| Bid | 14.28 |
| Bid Size | 1 |
| Book Value | 2.71 |
| City | Châtillon |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | France |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 13.54 |
| Current Ratio | 3.718 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,786,665,600 |
| Day High | 14.38 |
| Day Low | 13.45 |
| Debt To Equity | 4.8 |
| Display Name | DBV |
| Earnings Call Timestamp End | 1,784,235,600 |
| Earnings Call Timestamp Start | 1,784,235,600 |
| Earnings Timestamp | 1,784,232,000 |
| Earnings Timestamp End | 1,793,217,600 |
| Earnings Timestamp Start | 1,793,217,600 |
| Ebitda | -174,762,000 |
| Ebitda Margins | 0.0 |
| Enterprise To Ebitda | -3.629 |
| Enterprise To Revenue | 125.921 |
| Enterprise Value | 634,138,304 |
| Eps Current Year | -0.4745 |
| Eps Forward | -0.53637654 |
| Eps Trailing Twelve Months | -3.27 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 14.861 |
| Fifty Day Average Change | -1.3210001 |
| Fifty Day Average Change Percent | -0.08889039 |
| Fifty Two Week Change Percent | 56.97168 |
| Fifty Two Week High | 26.185 |
| Fifty Two Week High Change | -12.6449995 |
| Fifty Two Week High Change Percent | -0.48291007 |
| Fifty Two Week Low | 8.7 |
| Fifty Two Week Low Change | 4.84 |
| Fifty Two Week Low Change Percent | 0.55632186 |
| Fifty Two Week Range | 8.7 - 26.185 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,413,984,600,000 |
| Float Shares | 34,939,888 |
| Forward Eps | -0.53637654 |
| Forward P E | -25.24346 |
| Free Cashflow | -104,847,504 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 170 |
| Fullday Change | -0.87 |
| Fullday Change Percent | -6.03747 |
| Fullday Price | 13.72 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 1.0 |
| Gross Profits | 5,036,000 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.0 |
| Held Percent Institutions | 0.40980998 |
| Implied Shares Outstanding | 62,845,812 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Is Earnings Date Estimate | 0 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Last Split Date | 1,717,718,400 |
| Last Split Factor | 1:2 |
| Long Business Summary | DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products in France. Its product pipeline comprising Viaskin Peanut, an immunotherapy product, which has completed Phase 3 clinical trial for the treatment of peanut allergies; and Viaskin Milk which is in Phase 1/2 clinical trial for the treatment of immunoglobulin E (IgE) mediated or cow's milk protein allergy and eosinophilic esophagitis. The company's earlier stage research programs include celiac disease. In addition, the company develops Viaskin technology platform, a platform to potentially treat food allergy. It has a collaboration with Nestlé Health Science to develop MAG1C, a ready-to-use atopy patch test for the diagnosis of non-IgE mediated CMPA in infants and toddlers. DBV Technologies S.A. was incorporated in 2002 and is headquartered in Châtillon, France. |
| Long Name | DBV Technologies S.A. |
| Market | us_market |
| Market Cap | 850,932,288 |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_7406282 |
| Most Recent Quarter | 1,782,777,600 |
| Net Income To Common | -175,947,008 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 907,481,091 |
| Number Of Analyst Opinions | 6 |
| Open | 14.38 |
| Operating Cashflow | -169,280,992 |
| Operating Margins | -72.285706 |
| Payout Ratio | 0.0 |
| Phone | 33 1 55 42 78 78 |
| Post Market Change | 0.1800003 |
| Post Market Change Percent | 1.3293966 |
| Post Market Price | 13.72 |
| Post Market Time | 1,787,957,349 |
| Previous Close | 14.41 |
| Price Eps Current Year | -28.5353 |
| Price Hint | 2 |
| Price To Book | 4.9963098 |
| Price To Sales Trailing12 Months | 168.96988 |
| Profit Margins | 0.0 |
| Quick Ratio | 3.54 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | -0.87 |
| Regular Market Change Percent | -6.03747 |
| Regular Market Day High | 14.38 |
| Regular Market Day Low | 13.45 |
| Regular Market Day Range | 13.45 - 14.38 |
| Regular Market Open | 14.38 |
| Regular Market Previous Close | 14.41 |
| Regular Market Price | 13.54 |
| Regular Market Time | 1,787,947,201 |
| Regular Market Volume | 146,054 |
| Return On Assets | -0.60605 |
| Return On Equity | -1.4268401 |
| Revenue Growth | -0.533 |
| Revenue Per Share | 0.085 |
| Sand P52 Week Change | 0.20504117 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 62,845,812 |
| Shares Percent Shares Out | 0.025999999 |
| Shares Short | 1,633,383 |
| Shares Short Previous Month Date | 1,784,073,600 |
| Shares Short Prior Month | 1,470,719 |
| Short Name | DBV Technologies S.A. |
| Short Percent Of Float | 0.025999999 |
| Short Ratio | 4.31 |
| Source Interval | 15 |
| Symbol | DBVT |
| Target High Price | 55.708 |
| Target Low Price | 5.891078 |
| Target Mean Price | 41.325806 |
| Target Median Price | 47.098495 |
| Total Cash | 174,900,000 |
| Total Cash Per Share | 2.955 |
| Total Debt | 7,700,000 |
| Total Revenue | 5,036,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -3.27 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 18.1414 |
| Two Hundred Day Average Change | -4.6013994 |
| Two Hundred Day Average Change Percent | -0.25364083 |
| Type Disp | Equity |
| Volume | 146,054 |
| Website | https://www.dbv-technologies.com |
| Zip | 92,320 |